赛诺医疗8天4板，神经介入器械获FDA突破认定+反内卷政策利好

Core Insights - The stock of Sainuo Medical has increased by 19.99%, achieving four trading halts within eight trading days, with a latest price of 41.48 yuan and a total market capitalization of 17.258 billion yuan [1] Group 1: Company Developments - Sainuo Medical's subsidiary, Sainuo Shenchang, has received breakthrough medical device designation from the FDA for its COMETIU self-expanding intracranial drug-coated stent system and COMEX balloon microcatheter, marking it as the world's first product for treating intracranial atherosclerotic stenosis and the first domestic neuro-interventional device to achieve this recognition, enhancing its technological leadership in the neuro-interventional field [1] Group 2: Industry Context - According to a report from CITIC Securities, the high-level policy direction emphasizes "anti-involution" and "optimizing centralized procurement not solely based on low prices," which supports the development of innovative medical device industries and enhances expectations for industry valuation recovery [1] - Sainuo Medical is primarily involved in sectors such as medical devices, neuro-intervention, cardiovascular intervention, brain-computer interfaces, and centralized procurement [1]